Apheresis Market: Market Growth and Future Growth (2034)

The apheresis market has gained significant momentum in recent years, playing a critical role in modern medical treatments, especially for patients requiring specific blood components. Apheresis is a specialized medical technology that involves removing blood from a patient or donor, separating its components (such as plasma or platelets), and returning the remaining elements to the body. With a growing demand for targeted blood component transfusions, the apheresis market continues to expand at a healthy pace.

Get a free sample report: https://shorturl.at/V6I9r

In 2024, the global apheresis market was valued at USD 2.68 billion. The market is projected to grow at a CAGR of 9.20% from 2025 to 2034, reaching approximately USD 6.46 billion by 2034. This growth reflects the increasing prevalence of chronic diseases, advanced therapies for autoimmune disorders, and rising reliance on blood products globally.

Apheresis Market Size and Share Overview

The apheresis market has evolved from a niche medical procedure to a cornerstone of therapeutic and donation practices worldwide.

2024 Market Value: USD 2.68 Billion

2034 Projected Market Value: USD 6.46 Billion

Forecast Period CAGR: 9.20%

North America currently holds the largest market share due to advanced healthcare systems, high adoption of apheresis procedures, and increasing cases of hematological diseases. Meanwhile, Asia-Pacific is poised for rapid expansion, fueled by rising healthcare investment, improving infrastructure, and growing awareness of therapeutic apheresis.

Market Dynamics and Emerging Trends in the Apheresis Sector

Increasing Demand for Blood Components

One of the primary drivers of the apheresis market is the rising demand for plasma, platelets, and red blood cells in hospitals and clinics. Apheresis enables precise extraction of these components, reducing donor burden and improving therapeutic efficiency.

Rise in Chronic and Autoimmune Disorders

Conditions such as Guillain-Barré syndrome, multiple sclerosis, and myasthenia gravis often require plasma exchange through apheresis. The increasing prevalence of such diseases is expanding the scope of therapeutic apheresis.

Technological Advancements in Apheresis Devices

Innovations in centrifugal and membrane separation technologies, along with automated systems, are making apheresis procedures more efficient, safer, and accessible across healthcare settings.

Growth in Stem Cell Therapy and Oncology

Apheresis is integral to stem cell harvesting and leukapheresis in cancer treatment. The surge in stem cell transplantation and CAR-T cell therapy is positively impacting market growth.

Read full report with table of content: https://shorturl.at/MwWQ7

Key Growth Drivers of the Apheresis Market

Expanding Applications in Therapeutic Settings

Apheresis is now commonly used for therapeutic plasma exchange, red cell exchange, and LDL apheresis in treating various metabolic, neurological, and renal disorders.

Increased Use in Donor Apheresis

Blood donation centers globally are adopting donor apheresis techniques to collect high-purity components such as platelets and plasma, maximizing efficiency and safety.

Favorable Regulatory and Reimbursement Policies

In developed countries, reimbursement for apheresis procedures has improved, encouraging healthcare providers to adopt advanced technologies and treatment protocols.

Aging Population and Rising Surgical Procedures

With the aging global population and increase in complex surgeries, the demand for blood component support is on the rise, indirectly boosting the apheresis market.

Market Opportunities and Challenges in Apheresis

Growth Potential in Emerging Economies

Developing regions like Latin America, Southeast Asia, and the Middle East are witnessing increased healthcare investments and growing need for advanced blood therapies, offering untapped market opportunities.

Increasing Use in Pediatrics and Neonatal Care

Advances in pediatric and neonatal care are expanding the use of apheresis in treating congenital and genetic conditions such as hemolytic disease of the newborn.

Challenges in High Equipment Cost

Apheresis machines and disposables are expensive, which may limit their adoption in low-resource settings, particularly in rural or underfunded hospitals.

Limited Awareness and Training

In many regions, there is a shortage of trained personnel and awareness about apheresis, which can hinder procedure adoption and limit its benefits.

Recent Developments in the Global Apheresis Market

Haemonetics Corporation introduced a next-gen software update for its automated apheresis platform to enhance user interface and patient monitoring.

Terumo BCT expanded its therapeutic apheresis portfolio by launching updated kits tailored for COVID-19-related plasma exchange.

Asahi Kasei Medical Co. Ltd received regulatory approval in Europe for its novel plasma fractionation filters, designed to improve the safety of immunotherapy treatments.

Fresenius Kabi expanded its presence in Latin America by setting up new service centers for apheresis equipment maintenance and support.

Miltenyi Biotec launched upgraded cell separation technologies used in immunotherapy, enabling more precise leukapheresis.

Market Growth and Future Outlook

With advancements in medical technology and increasing global awareness of blood-related therapies, the apheresis market is set for continuous growth. Key forecasts include:

Rising demand for personalized medicine and cell-based therapies to significantly drive leukapheresis.

Automation and AI integration in apheresis systems to reduce operator dependency and procedural errors.

Widespread adoption of disposable kits and software-integrated platforms for data recording and analytics.

Collaborations between public blood banks and private healthcare facilities to standardize apheresis procedures.

The integration of digital technologies, enhanced donor management systems, and a shift toward precision medicine will further solidify apheresis as a standard in modern healthcare.

Competitive Landscape: Key Players Shaping the Apheresis Market
Nikkiso Co., Ltd.

A global leader in medical technology, Nikkiso offers advanced apheresis systems for therapeutic and donor applications, focusing on precision and patient safety.

Asahi Kasei Medical Co. Ltd

Renowned for its Plasmaflo and Hemosorba systems, Asahi Kasei is a dominant player in plasma exchange and immunoadsorption markets.

B. Braun Melsungen AG

Offers a comprehensive range of apheresis devices and consumables, especially for plasma exchange and lipid apheresis, across Europe and Asia.

Fresenius SE & Co. KGaA

Operates globally with its Fresenius Kabi division, offering integrated apheresis solutions, maintenance services, and staff training programs.

Terumo BCT, Inc

A market leader in automated blood collection and cell therapy systems, Terumo BCT plays a pivotal role in advancing therapeutic and donor apheresis.

Haemonetics Corporation

Known for its NexSys PCS® and MCS+ systems, Haemonetics dominates the donor apheresis space, particularly in platelet and plasma collection.

Mallinckrodt

Specializes in plasma-based therapies and supports apheresis for autoimmune disease management with a strong presence in the U.S. market.

Kaneka Corporation

Focuses on lipid apheresis and immunoadsorption technologies. Its selective filtration systems are used in treating cardiovascular and renal diseases.

Kawasumi Laboratories, Inc.

Offers blood bag systems and disposable apheresis kits, with strong distribution networks across Japan, Southeast Asia, and the Middle East.

Miltenyi Biotec

Key player in leukapheresis and stem cell separation for cancer immunotherapy and research applications. Focuses on precision cellular technologies.

Infomed

Provides compact, modular apheresis systems that are widely used in dialysis centers and outpatient care setups, particularly in Europe.

Toray Medical Co., Ltd.

A well-known Japanese brand offering selective apheresis filters and membranes designed for autoimmune and metabolic disease treatments.

Frequently Asked Questions (FAQs)

What is the current size of the global apheresis market?
As of 2024, the apheresis market is valued at USD 2.68 Billion.

What is the expected growth rate of the apheresis market?
The market is projected to grow at a CAGR of 9.20% from 2025 to 2034.

Which factors are driving the growth of the apheresis market?
Growth is driven by increasing demand for blood components, chronic disease prevalence, advancements in apheresis systems, and adoption in stem cell therapy.

Who are the key players in the apheresis industry?
Major players include Haemonetics, Terumo BCT, Fresenius, Asahi Kasei, Nikkiso, B. Braun, and Miltenyi Biotec.

Which region leads the global apheresis market?
North America leads the market due to advanced infrastructure and high awareness, while Asia-Pacific is expected to grow rapidly.

What are the main applications of apheresis?
Applications include plasma exchange, red cell exchange, leukapheresis, plateletpheresis, and stem cell harvesting.

Is apheresis used in cancer treatment?
Yes, particularly in leukapheresis, where white blood cells are removed to support cancer therapies like CAR-T cell treatment.

What challenges does the apheresis market face?
Key challenges include high device costs, limited awareness in developing regions, and the need for trained professionals.

The apheresis market represents a dynamic and rapidly expanding segment of the global healthcare industry. As the world moves toward personalized and precision therapies, apheresis will continue to serve as a vital tool in treating chronic diseases, supporting organ transplants, and enabling advanced research in immunotherapy.

Find More Report:

Topical Skin Infection Treatment Drug Pipeline Analysis: https://shorturl.at/w00pe

Warm Autoimmune Hemolytic Anemia Drug Pipeline Analysis: https://shorturl.at/SylfP

Spinal Fusion Drug Pipeline Analysis: https://shorturl.at/yVZVr

Recurrent or Metastatic Head and Neck Cancer Drug Pipeline Analysis: https://shorturl.at/0T4vA

Synovial Sarcoma Drug Pipeline Analysis: https://shorturl.at/gLD55

Media Contact:

Company Name: Claight Corporation
Contact Person: Deepanshu Choudhary, Digital Marketing
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others. Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

This release was published on openPR.